Clinical trial
Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer
NCT00202969 · Taiho Pharmaceutical Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00202969 |
|---|---|
| Title | Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer |
| Official title | An Open-label, Multicenter, Randomized, 3 Arm Study of S-1 Compared With S-1/CDDP, or S-1/CDDP Compared With 5-FU/CDDP in Patients With Advanced Gastric Cancer Previously Untreated With Chemotherapy for Advanced Disease |
| Lead sponsor | Taiho Pharmaceutical Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Drug |
| Interventions | S-1, S-1 plus CDDP, 5-FU plus CDDP |
| Enrollment | 180 |
| Start date | Jul 1, 2005 |
| Primary completion | Jan 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Jul 7, 2011 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: